Altimmuneincis A Clinical Stage Biopharmaceutical Company Based In Gaithersburgmarylandfounded In 1997 And Rebranded In 2015Altimmune Specializes In Peptide Based Therapeutics Aimed At Treating Metabolic And Liver Diseasesthe Company Has Approximately 59 Employees And Is Focused On Developing Innovative Treatments For Obesity And Metabolic Dysfunction Associated Steatohepatitismashthe Company S Lead Productpemvidutideis A Glp 1 Glucagon Dual Receptor Agonist Currently In Phase 3 Trials For Obesity And Phase 2 For Mashaltimmune Operates As A Research Driven Organizationmanaging Clinical Trials And Leveraging Its Expertise In Peptide Chemistry And Immunologythe Company Has Also Made Strategic Acquisitionsincluding Spitfire Pharma In 2019Which Enhanced Its Pipelinealtimmune Is Committed To Advancing Its Clinical Programs And Forming Partnerships Within The Healthcare And Pharmaceutical Sectors
No conferences found for this company.
| Company Name | Altimmune Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
